Basic Information
RNALocate ID: | RLID:01001680 |
RNA Symbol: | hsa-miR-223-3p |
Localization: | Endoplasmic reticulum membrane |
RNA Information
RNA Name: | hsa-miR-223 |
RNA ID: | miRBase:MIMAT0000280 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 32451872 |
Tissue/Cell Line: | Cortical tissue |
Method: | Subcellular fractionation assay|TaqMan miRNA assay |
Description: | MiRNA TaqMan assays with preamplification were employed to detect whether miRNAs were present in MAMs. The analysis revealed that several miRNAs were detected in the MAM fractions isolated from both human (Suppl. Table1) and rat (Suppl. Table2) cortex. These include three miRNAs, miR-146a, miR-142-3p, and miR-142-5p, that were previously identified to be highly enriched in rat hippocampal mitochondria [30, 31], as well as several other miRNAs including miR-223 and two neuronal-enriched miRNAs, miR-124 and miR-107. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11001553 | Exosome | Dendritic cells (in vitro differentiated Langerhans cells)|Healthy plasma|Mast cells (HMC-1 cell line)|PCa patient plasma | 25267620 |
RLID:11001554 | Exosome | Macrophages | 27396686 |
RLID:11001555 | Exosome | B cell line (Raji)|Primary dendritic cells | 21505438 |
RLID:11001556 | Exosome | Breast cancer cell lines (HEK-293T|MDA-MB-231|SKBR3)|Macrophages | 21939504 |
RLID:11001557 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11001558 | Exosome | Breast milk | 22211110 |
RLID:11001559 | Exosome | Brain tissue | 23382797 |
RLID:11001560 | Exosome | Plasma | 23663360 |
RLID:11001561 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001562 | Exosome | Plasma | 24130905 |
RLID:11001563 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11001564 | Exosome | Saliva | 25376581 |
RLID:11001565 | Microvesicle | Liver resident stem cells|Mesenchymal stem cells | 20668554 |
RLID:11001566 | Microvesicle | Plasma | 23077538 |
RLID:11001567 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000065 | Exosome | Blood|Breast milk|Mast cells | |
RLID-D:11000339 | Microvesicle | Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-223-3p | Inflammatory bowel disease | MNDR-E-MI-31154 |
MNDR | hsa-miR-223-3p | Splenic marginal zone lymphoma | MNDR-E-MI-31155 |
MNDR | hsa-miR-223-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-31156 |
MNDR | hsa-miR-223-3p | Oral squamous cell carcinoma | MNDR-E-MI-31157 |
MNDR | hsa-miR-223-3p | Medulloblastoma | MNDR-E-MI-31158 |
MNDR | hsa-miR-223-3p | Small intestinal neuroendocrine tumor | MNDR-E-MI-31159 |
MNDR | hsa-miR-223-3p | Lymphoma | MNDR-E-MI-31160 |
MNDR | hsa-miR-223-3p | Lymphoma non-hodgkin | MNDR-E-MI-31161 |
MNDR | hsa-miR-223-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-31162 |
MNDR | hsa-miR-223-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-31163 |
MNDR | hsa-miR-223-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-31164 |
MNDR | hsa-miR-223-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-31165 |
MNDR | hsa-miR-223-3p | Acute promyelocytic leukemia | MNDR-E-MI-31166 |
MNDR | hsa-miR-223-3p | Breast cancer luminal | MNDR-E-MI-31167 |
MNDR | hsa-miR-223-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31168 |
MNDR | hsa-miR-223-3p | Hereditary neutrophilia | MNDR-E-MI-31169 |
MNDR | hsa-miR-223-3p | Small intestine cancer | MNDR-E-MI-31170 |
MNDR | hsa-miR-223-3p | Dermatomyositis | MNDR-E-MI-31171 |
MNDR | hsa-miR-223-3p | Prostate cancer | MNDR-E-MI-31172 |
MNDR | hsa-miR-223-3p | Chronic lymphocytic leukemia | MNDR-E-MI-31173 |
MNDR | hsa-miR-223-3p | Gastric cancer | MNDR-E-MI-31174 |
MNDR | hsa-miR-223-3p | Gastric lymphoma | MNDR-E-MI-31175 |
MNDR | hsa-miR-223-3p | Alzheimer disease | MNDR-E-MI-31176 |
MNDR | hsa-miR-223-3p | Intracranial aneurysm | MNDR-E-MI-31177 |
MNDR | hsa-miR-223-3p | Bladder cancer | MNDR-E-MI-31178 |
MNDR | hsa-miR-223-3p | Esophageal carcinoma | MNDR-E-MI-31179 |
MNDR | hsa-miR-223-3p | Sarcoma | MNDR-E-MI-31180 |
MNDR | hsa-miR-223-3p | Dysautonomia familial | MNDR-E-MI-31181 |
MNDR | hsa-miR-223-3p | Polycystic ovary syndrome | MNDR-E-MI-31182 |
MNDR | hsa-miR-223-3p | Duchenne muscular dystrophy | MNDR-E-MI-31183 |
MNDR | hsa-miR-223-3p | Primary biliary cirrhosis | MNDR-E-MI-31184 |
MNDR | hsa-miR-223-3p | Leukemia | MNDR-E-MI-31185 |
MNDR | hsa-miR-223-3p | Huntington disease | MNDR-E-MI-31186 |
MNDR | hsa-miR-223-3p | Chorea | MNDR-E-MI-31187 |
MNDR | hsa-miR-223-3p | Cardiovascular disease | MNDR-E-MI-31188 |
MNDR | hsa-miR-223-3p | Lung cancer | MNDR-E-MI-31189 |
MNDR | hsa-miR-223-3p | Kawasaki disease | MNDR-E-MI-31190 |
MNDR | hsa-miR-223-3p | Down syndrome | MNDR-E-MI-31191 |
MNDR | hsa-miR-223-3p | Parkinson disease | MNDR-E-MI-31192 |
MNDR | hsa-miR-223-3p | Basal-like breast cancer | MNDR-E-MI-31193 |
MNDR | hsa-miR-223-3p | Thyroid cancer | MNDR-E-MI-31194 |
MNDR | hsa-miR-223-3p | Pancreatic cancer | MNDR-E-MI-31195 |
MNDR | hsa-miR-223-3p | HCV | MNDR-E-MI-31196 |
MNDR | hsa-miR-223-3p | Melanoma | MNDR-E-MI-31197 |
MNDR | hsa-miR-223-3p | Rectum adenocarcinoma | MNDR-E-MI-31198 |
MNDR | hsa-miR-223-3p | Nephroblastoma | MNDR-E-MI-31199 |
MNDR | hsa-miR-223-3p | Colon cancer | MNDR-E-MI-31200 |
MNDR | hsa-miR-223-3p | Essential thrombocythemia | MNDR-E-MI-31201 |
MNDR | hsa-miR-223-3p | Ischemic attack transient | MNDR-E-MI-31202 |
MNDR | hsa-miR-223-3p | Colon adenocarcinoma | MNDR-E-MI-31203 |
MNDR | hsa-miR-223-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31204 |
MNDR | hsa-miR-223-3p | Ovarian cancer | MNDR-E-MI-31205 |
MNDR | hsa-miR-223-3p | Asthma | MNDR-E-MI-31206 |
MNDR | hsa-miR-223-3p | Pulmonary tuberculosis | MNDR-E-MI-31207 |
MNDR | hsa-miR-223-3p | Carcinoma ductal breast | MNDR-E-MI-31208 |
MNDR | hsa-miR-223-3p | Glioblastoma | MNDR-E-MI-31209 |
MNDR | hsa-miR-223-3p | Glioma | MNDR-E-MI-31210 |
MNDR | hsa-miR-223-3p | Nemaline myopathy | MNDR-E-MI-31211 |
MNDR | hsa-miR-223-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-31212 |
MNDR | hsa-miR-223-3p | Epilepsy temporal lobe | MNDR-E-MI-31213 |
MNDR | hsa-miR-223-3p | Osteosarcoma | MNDR-E-MI-31214 |
MNDR | hsa-miR-223-3p | Liposarcoma | MNDR-E-MI-31215 |
MNDR | hsa-miR-223-3p | Coronary artery disease | MNDR-E-MI-31216 |
MNDR | hsa-miR-223-3p | Inclusion body myositis | MNDR-E-MI-31217 |
MNDR | hsa-miR-223-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-31218 |
MNDR | hsa-miR-223-3p | Meningioma | MNDR-E-MI-31219 |
MNDR | hsa-miR-223-3p | Liver cancer | MNDR-E-MI-31220 |
MNDR | hsa-miR-223-3p | Uterine cancer | MNDR-E-MI-31221 |
MNDR | hsa-miR-223-3p | Cervical adenocarcinoma | MNDR-E-MI-31222 |
MNDR | hsa-miR-223-3p | Gastric adenocarcinoma | MNDR-E-MI-31223 |
MNDR | hsa-miR-223-3p | Pituitary adenoma | MNDR-E-MI-31224 |
MNDR | hsa-miR-223-3p | Lung squamous cell carcinoma | MNDR-E-MI-31225 |
MNDR | hsa-miR-223-3p | Lung adenocarcinoma | MNDR-E-MI-31226 |
MNDR | hsa-miR-223-3p | Thyroid carcinoma | MNDR-E-MI-31227 |
MNDR | hsa-miR-223-3p | Bladder urothelial carcinoma | MNDR-E-MI-31228 |
MNDR | hsa-miR-223-3p | Pancreatic adenocarcinoma | MNDR-E-MI-31229 |
MNDR | hsa-miR-223-3p | Carcinoma renal cell | MNDR-E-MI-31230 |
MNDR | hsa-miR-223-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-31231 |
MNDR | hsa-miR-223-3p | Clear cell renal cell carcinoma | MNDR-E-MI-31232 |
MNDR | hsa-miR-223-3p | Biliary tract cancer | MNDR-E-MI-31233 |
MNDR | hsa-miR-223-3p | Myelofibrosis | MNDR-E-MI-31234 |
MNDR | hsa-miR-223-3p | Esophageal cancer | MNDR-E-MI-31235 |
MNDR | hsa-miR-223-3p | Liver cirrhosis | MNDR-E-MI-31236 |
MNDR | hsa-miR-223-3p | HIV | MNDR-E-MI-31237 |
MNDR | hsa-miR-223-3p | Lung small cell carcinoma | MNDR-E-MI-31238 |
MNDR | hsa-miR-223-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-31239 |
MNDR | hsa-miR-223-3p | Fibromyalgia | MNDR-E-MI-31240 |
MNDR | hsa-miR-223-3p | Breast invasive carcinoma | MNDR-E-MI-31241 |
MNDR | hsa-miR-223-3p | Juvenile rheumatoid arthritis | MNDR-E-MI-31242 |
MNDR | hsa-miR-223-3p | Hepatocellular carcinoma | MNDR-E-MI-31243 |
MNDR | hsa-miR-223-3p | Embryonal cancer | MNDR-E-MI-31244 |
MNDR | hsa-miR-223-3p | B-cell lymphoma | MNDR-E-MI-31245 |
MNDR | hsa-miR-223-3p | Rheumatoid arthritis | MNDR-E-MI-31246 |
MNDR | hsa-miR-223-3p | T-cell leukemia | MNDR-E-MI-31247 |
MNDR | hsa-miR-223-3p | Malignant pleural mesothelioma | MNDR-E-MI-31248 |
MNDR | hsa-miR-223-3p | Chronic kidney disease | MNDR-E-MI-31249 |
MNDR | hsa-miR-223-3p | Periodontitis | MNDR-E-MI-31250 |
MNDR | hsa-miR-223-3p | Chronic fatigue syndrome | MNDR-E-MI-31251 |
MNDR | hsa-miR-223-3p | Chronic myeloid leukemia | MNDR-E-MI-31252 |
MNDR | hsa-miR-223-3p | Hodgkin lymphoma | MNDR-E-MI-31253 |
MNDR | hsa-miR-223-3p | Burkitt lymphoma | MNDR-E-MI-31254 |
MNDR | hsa-miR-223-3p | Dementia vascular | MNDR-E-MI-31255 |
MNDR | hsa-miR-223-3p | Neuromyelitis optica | MNDR-E-MI-31256 |
MNDR | hsa-miR-223-3p | Psoriasis | MNDR-E-MI-31257 |
MNDR | hsa-miR-223-3p | Skin cutaneous melanoma | MNDR-E-MI-31258 |
MNDR | hsa-miR-223-3p | Skin melanoma | MNDR-E-MI-31259 |
MNDR | hsa-miR-223-3p | Acute myelocytic leukemia | MNDR-E-MI-31260 |
MNDR | hsa-miR-223-3p | Colorectal cancer | MNDR-E-MI-31261 |
MNDR | hsa-miR-223-3p | Multiple myeloma | MNDR-E-MI-31262 |
MNDR | hsa-miR-223-3p | Acute lymphocytic leukemia | MNDR-E-MI-31263 |
MNDR | hsa-miR-223-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-31264 |
MNDR | hsa-miR-223-3p | Nasopharyngeal cancer | MNDR-E-MI-31265 |
MNDR | hsa-miR-223-3p | Chronic kidney disease-mineral and bone disorder | MNDR-E-MI-31266 |
MNDR | hsa-miR-223-3p | Epstein-barr virus infections | MNDR-E-MI-31267 |
MNDR | hsa-miR-223-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-31268 |
MNDR | hsa-miR-223-3p | Sarcopenia | MNDR-E-MI-31269 |
MNDR | hsa-miR-223-3p | Stroke lacunar | MNDR-E-MI-31270 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022781 |
TOP